Therefore, our findings revealed a coexpression module related with histological type and identified three candidate genes (MAFA-AS1, hsa-mir-338, and hsa-mir-891a) that possessed potential value as prognostic biomarkers or potential therapeutic targets of DLBCL. The gene discussed is MAFA; the disease is diffuse large B-cell lymphoma.